Working… Menu

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02583191
Recruitment Status : Terminated (Recruitment was not as expected.)
First Posted : October 22, 2015
Last Update Posted : May 3, 2021
Charite University, Berlin, Germany
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 11, 2019
Actual Study Completion Date : August 19, 2019